Immune-Enhancing Treatment among Acute Necrotizing Pancreatitis Patients with Metabolic Abnormalities: A Post Hoc Analysis of a Randomized Clinical Trial.

Xiaofei Huang Wenjian Mao Xingxing Hu Fengxia Qin Hui Zhao Aiping Zhang Xinyu Wang Christian Stoppe Dandan Zhou Lu Ke Haibin Ninull null

Published in: Gut and liver (2024)

: Among ANP patients with hyperglycemia, immune-enhancing Tα1 treatment was associated with a reduced risk of IPN (ClinicalTrials.gov, Registry number: NCT02473406).

Keyphrases

liver failure
combination therapy
intensive care unit
hepatitis b virus
replacement therapy
aortic dissection